Literature DB >> 8382895

Pathological and experimental investigations in a case of gigantism.

I Fazekas1, E Pásztor, F Slowik, K Bálint, I Dobronyi, E Bácsy, A Gyévai, F Péter, L Blatniczky, I Varga.   

Abstract

A pituitary adenoma was transsphenoidally removed from a 4.5-year-old girl suffering from gigantism. Prior to the operation both the growth hormone (GH) and the prolactin (PRL) levels in the serum were elevated. By light microscopy the tumor appeared to be an acidophilic adenoma. Two distinct cell types, the densely granulated and the sparsely granulated cells, could be distinguished by electron microscopy. Double immunolabeling revealed the presence of GH alone in some densely granulated cells and PRL alone in some sparsely granulated cells, as well as GH and PRL co-localized in both of the morphologically distinguished cell types. Both cell types were identified in the monolayer and the suspension cultures by electron microscopy. GH and PRL concentrations in the culture media were measured by radioimmunoassay. The basal secretion of growth hormone was almost uniform during the 3-week cell culture period. GH and PRL release was significantly inhibited by bromocriptine. Our studies revealed a bimorphous and bihormonal mixed adenoma in childhood.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382895     DOI: 10.1007/bf00227764

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Hormone secretion by dispersed cell cultures of human pituitary adenomas: effects of theophylline, thyrotropin-releasing hormone, somatostatin, and 2-bromo-alpha-ergocryptine.

Authors:  E F Adams; I E Brajkovich; K Mashiter
Journal:  J Clin Endocrinol Metab       Date:  1979-07       Impact factor: 5.958

2.  Histologic, ultrastructural and hormonal characterization of a pituitary tumor secreting both HGH and prolactin.

Authors:  H Guyda; F Robert; E Colle; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

3.  Single secretory granules contain both GH and prolactin in pituitary mixed type of adenoma.

Authors:  H Ishikawa; H Nogami; M Kamio; T Suzuki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

4.  Growth characteristics of human pituitary adenomas in tissue and cell cultures.

Authors:  L Gazsó; E Pásztor
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  Pituitary adenomas in childhood and adolescence.

Authors:  G Maira; C Anile
Journal:  Can J Neurol Sci       Date:  1990-02       Impact factor: 2.104

6.  Effect of bromocriptine, somatostatin, and oestradiol-17 beta on hormone secretion and ultrastructure of human pituitary tumours in vitro.

Authors:  R A Prysor-Jones; S J Kennedy; J P O'Sullivan; J S Jenkins
Journal:  Acta Endocrinol (Copenh)       Date:  1981-09

7.  The acromegaly--gigantism syndrome. Report of four cases treated surgically.

Authors:  P Zampieri; M Scanarini; N Sicolo; G Andrioli; S Mingrino
Journal:  Surg Neurol       Date:  1983-12

8.  Pathology of growth hormone-producing tumors of the human pituitary.

Authors:  K Kovacs; E Horvath
Journal:  Semin Diagn Pathol       Date:  1986-02       Impact factor: 3.464

9.  Mammosomatotroph adenoma of the pituitary associated with gigantism and hyperprolactinemia. A morphological study including immunoelectron microscopy.

Authors:  I A Felix; E Horvath; K Kovacs; H S Smyth; D W Killinger; J Vale
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

10.  Prolactin and growth hormone-producing pituitary adenomas. An immunohistochemical and ultrastructural study.

Authors:  R V Lloyd; P W Gikas; W F Chandler
Journal:  Am J Surg Pathol       Date:  1983-04       Impact factor: 6.394

View more
  1 in total

1.  Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child.

Authors:  J Flitsch; D K Lüdecke; N Stahnke; J Wiebel; W Saeger
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.